S-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats

Clin Sci (Lond). 2000 Oct;99(4):315-20.

Abstract

In various experimental models, S-adenosylmethionine (SAMe) has been shown to reduce liver injury by preventing depletion of glutathione, one of the antioxidant systems that plays a critical role in defence against oxidative stress. On the other hand, alpha-tocopherol may be decreased in liver diseases, and treatment with this vitamin reduces liver injury in CCl(4)-treated rats. Since there is a close relationship among the different antioxidant systems (mainly glutathione, alpha-tocopherol and ascorbic acid), we have assessed whether, as well as restoring hepatic glutathione content, SAMe has any effect on liver alpha-tocopherol and ascorbic acid levels in CCl(4)-injured rats. Four groups of seven male Wistar rats treated for 9 weeks were studied: rats induced to cirrhosis with CCl(4), rats induced to cirrhosis plus SAMe administration (10 mg x kg(-1) x day(-1)) and their respective controls. Liver samples were obtained for measuring levels of glutathione, alpha-tocopherol, ascorbic acid and thiobarbituric acid-reactive substances (TBARS), and hydroxyproline concentration as an index of collagen content. The hydroxyproline content was higher in CCl(4)-injured rats than in the control group (4.4+/-1.8 and 1.1+/-0.3 micromol/g respectively; P<0.05). In CCl(4)-injured rats, SAMe administration decreased collagen content (2.7+/-1.0 microl/g; P<0.05) and TBARS, and corrected glutathione depletion. alpha-Tocopherol was significantly lower in CCl(4)-injured rats than in controls (17.3+/-4.9 and 23.0+/-4.0 micromol/g respectively; P<0.05). By contrast, alpha-tocopherol levels were similar (23.8+/-5.1 micromol/g) in CCl(4)-injured rats receiving SAMe and in controls. In CCl(4)-injured rats, liver ascorbic acid was decreased in comparison with controls (4.9+/-1.8 and 8.2+/-1.0 micromol/g respectively; P<0.05), levels which were not replenished by SAMe (4.6+/-0.4 micromol/g). In conclusion, SAMe not only decreases fibrosis and protects against hepatic glutathione depletion, but has a further antioxidant effect of preventing alpha-tocopherol depletion in CCl(4)-injured rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Ascorbic Acid Deficiency / drug therapy*
  • Ascorbic Acid Deficiency / etiology
  • Carbon Tetrachloride Poisoning / complications*
  • Glutathione / analysis
  • Hydroxyproline / analysis
  • Liver / chemistry
  • Liver Cirrhosis, Experimental / drug therapy*
  • Liver Cirrhosis, Experimental / etiology
  • Male
  • Rats
  • S-Adenosylmethionine / therapeutic use*
  • Thiobarbituric Acid Reactive Substances / analysis
  • Vitamin E / analysis
  • Vitamin E Deficiency / drug therapy*
  • Vitamin E Deficiency / etiology

Substances

  • Antioxidants
  • Thiobarbituric Acid Reactive Substances
  • Vitamin E
  • S-Adenosylmethionine
  • Glutathione
  • Hydroxyproline